At ASMS 2026, the Technology Networks team spoke with Dr. Matthew Lewis, Vice President of Metabolomics and Lipidomics at Bruker Daltonics and Head of Markets at TOFWERK, to explore how next-generation time-of-flight mass spectrometry (TOF-MS) is shifting the paradigm of human exposome research. While traditional offline sampling flags historical exposure levels, it fails to provide the real-time, actionable data required to pinpoint contaminant origins or map sudden exposure spikes.
In this interview, Dr. Lewis explains how combining complementary ionization approaches can improve the detection of complex, trace-level airborne pollutants and metals, and explores the growing role of interdisciplinary collaboration in linking environmental exposures to human health outcomes.
